The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
BELLWAVE-003: A phase 2 dose escalation, confirmation, and cohort expansion study of nemtabrutinib in hematologic malignancies.
 
Guilherme Fleury Perini
Honoraria - Abbvie; AstraZeneca; Janssen; MSD; Roche; Takeda
Consulting or Advisory Role - Abbvie; AstraZeneca; Janssen; MSD; Roche; Takeda
Speakers' Bureau - Abbvie; AstraZeneca; Janssen; MSD; Roche
Research Funding - AstraZeneca; Janssen; Kartos Therapeutics; MSD
Travel, Accommodations, Expenses - Abbvie; AstraZeneca; Janssen; MSD; Roche
 
Carolyn Owen
Honoraria - Abbvie; AstraZeneca; BeiGene; Incyte; Janssen; Merck; Novartis Canada Pharmaceuticals Inc; Roche Canada; Seagen
Research Funding - Abbvie (Inst); Acerta Pharma/AstraZeneca (Inst); Genentech (Inst); Janssen (Inst); Merck (Inst); Roche Canada (Inst)
 
Muhit Ozcan
Research Funding - Abbvie; Acerta Pharma/AstraZeneca; Bayer; Dr. Reddy's Laboratories; Janssen; Merck; Pfizer; Roche; Takeda
Travel, Accommodations, Expenses - Abbvie; Jazz Pharmaceuticals; Roche
 
Wojciech Jurczak
Consulting or Advisory Role - AstraZeneca; BeiGene; Roche
Research Funding - Acerta Pharma; BeiGene; Epizyme; Janssen-Cilag; MEI Pharma; Morphosys; Roche; Sandoz-Novartis; Takeda; TG Therapeutics; TG Therapeutics
 
Eva González Barca
Consulting or Advisory Role - Abbvie; BeiGene; EUSA Pharma; Gilead Sciences; Incyte; Janssen; Kyowa Kirin; Lilly O.; Takeda
Speakers' Bureau - Abbvie; Beigene; EUSA Pharma; Incyte; Janssen; Kyowa Kirin; Roche; Takeda
Travel, Accommodations, Expenses - Abbvie; EUSA Pharma; Janssen
 
Tomasz Wrobel
Honoraria - Amgen; Bristol-Myers Squibb/Celgene; Janssen-Cilag; Novartis; Roche
Consulting or Advisory Role - Amgen; BeiGene; Bristol-Myers Squibb/Celgene; Janssen-Cilag; Novartis; Roche; Sanofi
Research Funding - Roche
Expert Testimony - Abbvie; Amgen; Gilead Sciences; Janssen-Cilag
 
David Lavie
Consulting or Advisory Role - Abbvie; BMS; Novartis; Roche; Takeda
 
Arvind Chaudhry
Employment - American Oncology Network
 
Paolo Ghia
Honoraria - Abbvie; AstraZeneca; Beigene; Bristol-Myers Squibb; Janssen; Loxo@Lilly; MSD; Roche
Consulting or Advisory Role - Abbvie; AstraZeneca; Beigene; Bristol-Myers Squibb; Janssen; Loxo@Lilly; MSD; Roche
Research Funding - Abbvie; AstraZeneca; Bristol-Myers Squibb; Janssen
 
Yan Xu
Employment - Merck
Travel, Accommodations, Expenses - Merck
 
David Boardman
Employment - Merck
Stock and Other Ownership Interests - Merck
Travel, Accommodations, Expenses - Merck
 
Jing Yang
Employment - Merck
Stock and Other Ownership Interests - Merck
Travel, Accommodations, Expenses - Merck
 
Ohad Benjamini
Consulting or Advisory Role - Abbvie; AstraZeneca; Janssen